Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP

Last updated on 2022-05-01 History
Report ID 136555
Drug Identification Number 02139499
Brand name MAGNESIUM SULFATE INJECTION
Common or Proper name Magnesium Sulfate Injection 500 mg/mL SD Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MAGNESIUM SULFATE
Strength(s) 500MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-04-01
Actual start date 2021-04-01
Estimated end date 2022-04-30
Actual end date 2022-04-30
Shortage status Resolved
Updated date 2022-05-01
Company comments On 100% Allocation effective October 13, 2021.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2022-05-01 English Compare
v24 2022-04-22 French Compare
v23 2022-04-22 English Compare
v22 2022-04-22 English Compare
v21 2021-10-13 French Compare
v20 2021-10-13 English Compare
v19 2021-09-30 French Compare
v18 2021-09-30 English Compare
v17 2021-09-07 French Compare
v16 2021-09-07 English Compare
v15 2021-05-28 French Compare
v14 2021-05-28 English Compare
v13 2021-04-23 French Compare
v12 2021-04-23 English Compare
v11 2021-04-23 English Compare
v10 2021-04-06 French Compare
v9 2021-04-06 English Compare
v8 2021-04-05 French Compare
v7 2021-04-05 English Compare
v6 2021-04-05 English Compare

Showing 1 to 20 of 25